This is a single arm prospective trial that evaluates whole body diffusion weight imaging (DWI) compared to 18F-fludeoxyglucose (FDG) Positron Emission Tomography with Magnetic resonance imaging (PET/MRI) in participants with known metastatic cancer.
Phase:
NA
Details
Lead Sponsor:
University of California, San Francisco
Collaborators:
GE Healthcare Society of Abdominal Radiology
Treatments:
Fluorodeoxyglucose F18 Magnetic Resonance Spectroscopy